PX1 Research provides high-purity 30mg thymosin alpha-1 peptide vials optimized strictly for in vitro investigation, cellular signaling assays, and preclinical research models. Manufactured in GMP-compliant USA facilities, every lot undergoes rigorous third-party analytical verification to ensure exceptional chemical purity, sequence fidelity, and minimal endotoxin levels.
PX1 Research provides high-purity 30mg thymosin alpha-1 peptide vials optimized strictly for in vitro investigation, cellular signaling assays, and preclinical research models. Manufactured in GMP-compliant USA facilities, every lot undergoes rigorous third-party analytical verification to ensure exceptional chemical purity, sequence fidelity, and minimal endotoxin levels.
A thymosin alpha-1 peptide vial contains a 30mg lyophilized cake of synthesized 28-amino-acid peptide designed for laboratory research applications. Highly valued in immunological and cellular biology studies, this compound is supplied exclusively for in vitro assays, biochemical structural analysis, and animal model research to evaluate cell-mediated immune dynamics and signaling cascades.
Thymosin Alpha-1 (TA1) is an N-terminally acetylated peptide originally isolated from thymic tissue fraction 5. In laboratory settings, researchers utilize the stable thymosin alpha-1 peptide vial 30mg format to prepare precise concentration gradients for cell culture and molecular assays. As an established reference standard, TA1 provides consistent baseline performance in preclinical evaluations of peptide-receptor interactions.
Thymosin Alpha-1 possesses the primary sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH, giving it a molecular formula of C129H215N33O45 and an exact molecular weight of 3108.3 g/mol. The N-terminal acetylation imparts enzymatic resistance against specific exopeptidases, maintaining conformational integrity during prolonged in vitro experimentation.
In analytical chemistry workflows, verifying sequence identity requires high-resolution techniques. Researchers evaluating our research peptides catalog rely on detailed characterization data to confirm that the synthesized peptide mirrors native thymic peptides. The acidic nature of TA1—attributable to multiple glutamic and aspartic acid residues—dictates its solubility profile in aqueous buffer systems, making proper laboratory handling protocols essential.
Preclinical studies suggest that Thymosin Alpha-1 acts primarily through Toll-like receptor (TLR-7 and TLR-9) pathways within dendritic cells and macrophages. In vitro assays demonstrate that binding to these innate pattern recognition receptors initiates intracellular signaling through the MyD88-dependent pathway, subsequently triggering nuclear factor kappa B (NF-κB) translocation and transcription of downstream signaling molecules.
In cell culture models, exposure to TA1 has been shown to modulate cytokine expression patterns, specifically promoting the transcription of Interleukin-2 (IL-2), Interferon-gamma (IFN-γ), and Interleukin-12 (IL-12). Animal studies further indicate that TA1 plays a structural role in supporting T-cell differentiation, CD4+/CD8+ lymphocyte maturation, and natural killer (NK) cell activation. Investigators examining cellular immunity often explore these pathways within the broader context of our research library hub.
Maintaining rigorous quality control is critical when sourcing any thymosin alpha-1 peptide vial for sensitive bioassays. PX1 Research subjects every batch to comprehensive third-party testing in ISO 17025 accredited analytical laboratories, ensuring researchers receive fully characterized materials without batch-to-batch variance.
Purity is quantified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a baseline purity exceeding 98.0%. Molecular mass is confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS) to ensure correct peptide assembly. Furthermore, because bacterial contamination can alter cellular assays, our vials undergo Chromogenic Reagent Endotoxin Testing (LAL assay) to guarantee endotoxin levels remain below strictly controlled laboratory thresholds (<0.01 EU/mg).
When designing comparative preclinical trials, investigators often evaluate Thymosin Alpha-1 alongside other specialized signaling and structural peptides. Understanding the distinct mechanisms of these peptides allows researchers to select the optimal model for their specific experimental objectives.
While Thymosin Alpha-1 focuses primarily on T-cell maturation pathways via TLR activation, Thymosin Beta-4 10mg regulates actin sequestration and tissue remodeling networks. Similarly, LL-37 5mg operates as an antimicrobial host-defense peptide altering membrane permeability, whereas BPC-157 10mg acts via angiogenic signaling and focal adhesion kinase pathways. Researchers evaluating these distinct mechanisms can cross-reference findings within our immunomodulatory research guide.
Proper handling of lyophilized peptide vials ensures long-term stability and experimental reproducibility. When reconstituting a 30mg thymosin alpha-1 vial, researchers should maintain aseptic technique inside a certified laminar flow hood to avoid introducing airborne contaminants.
Lyophilized vials should be stored at -20°C or -80°C prior to reconstitution, protected from light and moisture. Reconstitution is typically performed using sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4). Avoid high-shear vortexing; gentle swirling allows complete dissolution. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene microtubes to prevent degradation caused by repeated freeze-thaw cycles.
In vitro models utilizing Thymosin Alpha-1 frequently focus on lymphocyte proliferation, major histocompatibility complex (MHC Class I) expression, and oxidative stress pathways. Researchers measure parameter shifts such as cell viability, cell surface marker expression, and apoptotic flux following controlled exposure to the peptide.
Preclinical rodent models have evaluated TA1 in contexts involving immune senescence, oncological cellular microenvironments, and viral antigen responses. Insights gained from these models help refine biochemical models of thymic hormone activity. Laboratories sourcing bulk compounds for multi-phase rodent trials often utilize our wholesale laboratory account services to maintain consistent lot numbers throughout extended research timelines.
Reliable procurement is vital for avoiding research delays. PX1 Research manufactures all research compounds within state-of-the-art, GMP-compliant facilities in the United States, providing complete lot traceability and batch consistency across every shipment.
Orders are dispatched same-day (Monday through Friday) directly from our distribution hubs in California and Arizona. Each thymosin alpha-1 peptide vial 30mg is shipped in temperature-stable packaging with an individualized Certificate of Analysis (COA) included, supporting institutional compliance and laboratory audit standards.
What is the primary function of a thymosin alpha-1 peptide vial in laboratory research?
A thymosin alpha-1 peptide vial provides a standardized, high-purity reference material for investigating cellular immune responses, T-cell maturation, cytokine pathways, and TLR signaling mechanisms in cell culture and animal models.
What purity level is guaranteed for the 30mg thymosin alpha-1 peptide vial?
PX1 Research guarantees a minimum analytical purity of 98.0% as verified by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
How should a lyophilized thymosin alpha-1 vial be stored upon receipt?
Lyophilized vials should be stored at -20°C for short-to-medium-term storage or at -80°C for long-term stability, kept away from light and humidity.
How is endotoxin contamination controlled in PX1 Research vials?
Every production lot undergoes LAL chromogenic endotoxin testing to ensure levels remain strictly below laboratory thresholds (<0.01 EU/mg), preventing non-specific immune activation in sensitive bioassays.
What solvent is recommended for reconstituting thymosin alpha-1 for in vitro assays?
Standard laboratory solvents include sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream assay.
How does Thymosin Alpha-1 differ structurally from Thymosin Beta-4?
Thymosin Alpha-1 is a 28-amino-acid peptide derived from thymic fraction 5 involved in immune signaling, whereas Thymosin Beta-4 is a 43-amino-acid actin-sequestering peptide focused on cellular migration and repair structures.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona with same-day dispatch (Monday–Friday).
Is a Certificate of Analysis (COA) provided with the thymosin alpha-1 peptide vial?
Yes, every lot includes a downloadable, third-party Certificate of Analysis detailing HPLC purity chromatograms, mass spectrometry verification, and endotoxin assay results.
Can institutional buyers order thymosin alpha-1 peptide vials in bulk?
Yes, verified academic institutions, biotechnology firms, and commercial laboratories can establish [wholesale lab accounts](/wholesale) for bulk procurement and dedicated lot reservations.
Are PX1 Research compounds suitable for human or veterinary administration?
No. All products supplied by PX1 Research are strictly for in vitro, cellular, and preclinical laboratory research use only. They are not for human or animal consumption, medical treatment, or diagnostic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.